Maria Guadalupe Guzmán (born January 19, 1952) is a Cuban virologist and doctor. She is the current director of Research, Diagnosis and Reference at the Research Center of the Pedro Kouri Institute (IPK) in Havana, Cuba.[1]
Guzmán is known for her pioneering research on the pathogenesis, diagnosis, and vaccination for dengue virus, the origin of dengue virus epidemics, and the recognizing of secondary infection as a major risk factor for dengue hemorrhagic fever.[2]
Life and Career
editAs a child, Maria Guadalupe Guzmán had an innate curiosity about the natural world. Before settling the focus of her study and research of virology and medicine, she had an interest in astronomy.[3]
After choosing the path of biology and medicine and beginning her science trajectory, Guzmán has worked in prestigious institutions of scientific research in Cuba, including CENIC (Centro Nacional de Investigaciones Científicas) and IPK (Institutio Pedro Kouri), and participated in prestigious collaborations with NGOs like the World Health Organization and Pan American Health Organization.[3]
In 1980, Guzman married Gustavo Kourí, the director of IPK, who was a mentor to her later academic and research career. The couple lived in IPK for over 30 years, and dedicated their lives to research in virology.[4]
Research
editGuzmán has contributed to virology research for over 30 years and has made over 300 publications as of 2024, with a specific focus on dengue hemorrhagic fever and arboviruses. (1) The first epidemic that she encountered in her career was the hemorrhagic dengue epidemic of 1981, from which she would continue to delve deeper into research around this disease and similar epidemics like this.[4] Guzmán is the senior researcher to over 70 projects nationally and internationally and the educator for over 130 courses in Cuba and other regions of the Americas. She also holds seven patents and has written 20 book chapters.[5]
Guzmán is a member of the Organization of Women Scientists of the third world, Dengue Working Group of the Pan American Health Organization (PAHO) and American Society of Tropical Medicine. She also serves on the Advisory Committee on Dengue and JBD vaccines of the World Health Organization.[6] From 2010 to 2018, Guzmán served as the director of the WHO/PAHO Collaborating Center for Dengue and its Control, and the president of Network of Diagnostic Laboratories of Arbovirus of the Americas (RELDA). She is the current president of the Cuban Society of Microbiology and Parasitology. Guzmán is a distinguished professor and a contributor to Cuba's Public Health Encyclopedia, where she is the author of the chapter on Dengue Fever.[1]
During the COVID-19 pandemic, Doctor Maria Guadalupe Guzman also participated in national research on SARS-CoV-2 diagnosis, vaccination, and surveillance of its many variants that emerged as the pandemic developed.[2]
Awards
editGuzmán is the recipient of 2021's International Prize for Women in Science, hosted by UNESCO and the L'Oréal Foundation, awarded each year to five prominent woman scientists from each of the five regions of the world.[7] She is also the first Caribbean woman to receive this award.[5]
References
edit- ^ a b "Unesco premia a científica cubana por investigaciones sobre dengue". Cuban Debate. 2021-09-30. Retrieved 2024-05-09.
- ^ a b L'Oréal Caribe (2022-06-23). LOREAL UNESCO STORY OF CUBA PROFESSOR MARIA GUADALUPE GUZMAN TIRADO FWIS 2022 LAUREATE. Retrieved 2024-05-21 – via YouTube.
- ^ a b "For Women in Science 2022 : Maria Guadalupe Guzmán". www.loreal.com. Retrieved 2024-05-21.
- ^ a b "Una mujer ligada a la ciencia – OPS/OMS | Organización Panamericana de la Salud". www.paho.org (in Spanish). Retrieved 2024-05-21.
- ^ a b "UNESCO honors Cuba's IPK expert". Cuban News Agency. 2022-05-30. Retrieved 2024-05-09.
- ^ "María Guadalupe Guzmán Tirado". Cubanos Famosos (in Spanish). Retrieved 2024-05-21.
- ^ "Professor María Guadalupe Guzmán Tiradofor wins UNESCO award for pioneering work in environmental and life sciences". cuba-solidarity.org.uk. Retrieved 2024-05-21.
This article needs additional or more specific categories. (August 2024) |